References
- Arai K, Takano S, Teratani T, et al. (2008). S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr Cancer Drug Targets, 8, 243–52
- Chalmers SA, Eidelman AS, Ewer JC, et al. (2013). A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro. Cell Immunol, 282, 136–45
- Cohen PA, Ko JS, Storkus WJ, et al. (2012). Myeloid-derived suppressor cells adhere to physiological STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunological escape. Immunol Invest, 41, 680–710
- Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. (2012). Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol, 12, 253–68
- Hiratsuka S, Watanabe A, Aburatani H, Maru Y. (2006). Tumour mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nature Cell Biol, 8, 1369–75
- Ichikawa M, Williams R, Wang L, et al. (2011). S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res, 9, 133–48
- Kondo Y, Ueno Y, Kobayashi K, et al. (2010). Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes. J Infect Dis, 202, 202–13
- Kurt RA, Baher A, Wisner KP, et al. (2001). Chemokine receptor desensitization in tumor bearing mice. Cell Immunol, 207, 81–88
- Kwon CH, Moon HJ, Park HJ, et al. (2013). S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Mol Cells, 35, 226–34
- Lindau D, Gielen P, Kroesen M, et al. (2013). The immunosuppressive tumour network: Myeloid derived suppressor cells, regulatory T cells and natural killer T cells. Immunology, 138, 105–15
- Liu Y, Kosaka A, Ikeura M, et al. (2013). Premetastatic soil and prevention of breast cancer brain metastasis. Neuro Oncol, 15, 891–903
- Liu Z, Falo LD, You Z. (2011). Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T-cell dependent anti-tumor immunity. J Immunol, 187, 118–25
- Lukanidin E, Sleeman JP. (2012). Building the niche: The role of the S100 proteins in metastatic growth. Sem Cancer Biol, 22, 216–25
- McKiernan E, McDermott EW, Evoy D, et al. (2011). The role of S100 genes in breast cancer progression. Tumor Biol, 32, 441–50
- Monu NR, Frey AB. (2012). Myeloid-derived suppressor cells and anti-tumor T cells: A complex relationship. Immunol Invest, 41, 595–613
- Patel LR, Camacho DF, Shiozawa Y, et al. (2011). Mechanisms of cancer cell metastasis to the bone: A multistep process. Future Oncol, 7, 1285–97
- Piccinini AM, Midwood KS. (2010). DAMPening inflammation by modulating TLR signaling. Med Inflamm. doi: 10.1155/2010/672395
- Qu P, Boelte KC, Lin PC. (2012). Negative regulation of myeloid-derived suppressor cells in cancer. Immunol Invest, 41, 562–80
- Raber P, Ochoa AC, Rodriguez PC. (2012). Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: Mechanisms of T cell suppression and therapeutic perspectives. Immunol Invest, 41, 614–34
- Redig AJ, McAllister SS. (2013). Breast cancer as a systemic disease: A view of metastasis. J Internal Med, 274, 113–26
- Rose S, Misharin A, Perlman H. (2014). A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry, 81, 343–50
- Saha A, Lee Y, Zhang Z, et al. (2010). Lack of an endogenous anti-inflammatory protein in mice enhances colonization of B16F10 melanoma cells in the lungs. J Biol Chem, 285, 10822–31
- Sinha P, Okoro C, Foell D, et al. (2008). Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol, 181, 4666–75
- Van den Eynden GG, Majeed AW, Illemann M. (2013). The multifaceted role of the microenvironment in liver metastasis: Biology and clinical implications. Cancer Res, 73, 2031–43
- Wild CA, Bergmann C, Fritz G, et al. (2012). HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. Int Immunol, 24, 485–94
- Zhang Y, Davis C, Ryan J, et al. (2013). Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver. Clin Exp Mets, 30, 903–18